Healthcare

Innovation program showcases AI-enabled clinical and drug-discovery tools

A healthcare innovation program highlighted AI-enabled rehabilitation, sports biomechanics, organ-on-a-chip drug discovery, and stroke testing projects.

A Qatar healthcare innovation session featured five companies working on applications that included camera-based movement assessment and rehabilitation, AI-enabled sports biomechanics, automated patient-specific organ-on-a-chip platforms for drug discovery, microRNA-based cardiac regeneration, and gene-expression blood testing to distinguish ischemic stroke from stroke mimics. The projects span clinical assessment, rehabilitation, pharmaceutical research, cardiovascular medicine, and emergency diagnosis. The session’s focus was on moving innovations from development into clinical practice. These examples matter because they show AI being combined with sensing, laboratory testing, and automated experimentation rather than used only for conversational assistance. The source identifies the technologies and participating program context but does not report clinical outcomes or commercial deployment.

Original source: WISH

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI